Cargando…
Genetic Progression and the Waiting Time to Cancer
Cancer results from genetic alterations that disturb the normal cooperative behavior of cells. Recent high-throughput genomic studies of cancer cells have shown that the mutational landscape of cancer is complex and that individual cancers may evolve through mutations in as many as 20 different canc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2065895/ https://www.ncbi.nlm.nih.gov/pubmed/17997597 http://dx.doi.org/10.1371/journal.pcbi.0030225 |
_version_ | 1782137656063295488 |
---|---|
author | Beerenwinkel, Niko Antal, Tibor Dingli, David Traulsen, Arne Kinzler, Kenneth W Velculescu, Victor E Vogelstein, Bert Nowak, Martin A |
author_facet | Beerenwinkel, Niko Antal, Tibor Dingli, David Traulsen, Arne Kinzler, Kenneth W Velculescu, Victor E Vogelstein, Bert Nowak, Martin A |
author_sort | Beerenwinkel, Niko |
collection | PubMed |
description | Cancer results from genetic alterations that disturb the normal cooperative behavior of cells. Recent high-throughput genomic studies of cancer cells have shown that the mutational landscape of cancer is complex and that individual cancers may evolve through mutations in as many as 20 different cancer-associated genes. We use data published by Sjöblom et al. (2006) to develop a new mathematical model for the somatic evolution of colorectal cancers. We employ the Wright-Fisher process for exploring the basic parameters of this evolutionary process and derive an analytical approximation for the expected waiting time to the cancer phenotype. Our results highlight the relative importance of selection over both the size of the cell population at risk and the mutation rate. The model predicts that the observed genetic diversity of cancer genomes can arise under a normal mutation rate if the average selective advantage per mutation is on the order of 1%. Increased mutation rates due to genetic instability would allow even smaller selective advantages during tumorigenesis. The complexity of cancer progression can be understood as the result of multiple sequential mutations, each of which has a relatively small but positive effect on net cell growth. |
format | Text |
id | pubmed-2065895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-20658952007-11-29 Genetic Progression and the Waiting Time to Cancer Beerenwinkel, Niko Antal, Tibor Dingli, David Traulsen, Arne Kinzler, Kenneth W Velculescu, Victor E Vogelstein, Bert Nowak, Martin A PLoS Comput Biol Research Article Cancer results from genetic alterations that disturb the normal cooperative behavior of cells. Recent high-throughput genomic studies of cancer cells have shown that the mutational landscape of cancer is complex and that individual cancers may evolve through mutations in as many as 20 different cancer-associated genes. We use data published by Sjöblom et al. (2006) to develop a new mathematical model for the somatic evolution of colorectal cancers. We employ the Wright-Fisher process for exploring the basic parameters of this evolutionary process and derive an analytical approximation for the expected waiting time to the cancer phenotype. Our results highlight the relative importance of selection over both the size of the cell population at risk and the mutation rate. The model predicts that the observed genetic diversity of cancer genomes can arise under a normal mutation rate if the average selective advantage per mutation is on the order of 1%. Increased mutation rates due to genetic instability would allow even smaller selective advantages during tumorigenesis. The complexity of cancer progression can be understood as the result of multiple sequential mutations, each of which has a relatively small but positive effect on net cell growth. Public Library of Science 2007-11 2007-11-09 /pmc/articles/PMC2065895/ /pubmed/17997597 http://dx.doi.org/10.1371/journal.pcbi.0030225 Text en © 2007 Beerenwinkel et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Beerenwinkel, Niko Antal, Tibor Dingli, David Traulsen, Arne Kinzler, Kenneth W Velculescu, Victor E Vogelstein, Bert Nowak, Martin A Genetic Progression and the Waiting Time to Cancer |
title | Genetic Progression and the Waiting Time to Cancer |
title_full | Genetic Progression and the Waiting Time to Cancer |
title_fullStr | Genetic Progression and the Waiting Time to Cancer |
title_full_unstemmed | Genetic Progression and the Waiting Time to Cancer |
title_short | Genetic Progression and the Waiting Time to Cancer |
title_sort | genetic progression and the waiting time to cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2065895/ https://www.ncbi.nlm.nih.gov/pubmed/17997597 http://dx.doi.org/10.1371/journal.pcbi.0030225 |
work_keys_str_mv | AT beerenwinkelniko geneticprogressionandthewaitingtimetocancer AT antaltibor geneticprogressionandthewaitingtimetocancer AT dinglidavid geneticprogressionandthewaitingtimetocancer AT traulsenarne geneticprogressionandthewaitingtimetocancer AT kinzlerkennethw geneticprogressionandthewaitingtimetocancer AT velculescuvictore geneticprogressionandthewaitingtimetocancer AT vogelsteinbert geneticprogressionandthewaitingtimetocancer AT nowakmartina geneticprogressionandthewaitingtimetocancer |